Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

469results about "Tetrapeptides" patented technology

Antibody-drug conjugate, preparation method therefor, and use thereof

Provided are an antibody-drug conjugate, a preparation method therefor, and use thereof. The antibody-drug conjugate has a structure represented by the formula Ab-[M-L-E-D]x, has a superior drug-to-antibody ratio, and has an excellent targeted killing effect on various cancers or tumors.
Owner:SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD

Oligopeptide with melanin inhibition activity, tandem protein, composition and application thereof

PendingCN119019489AHas whitening activityconvenient whiteningCosmetic preparationsDipeptide ingredientsPigmentationsDrug product
The invention discloses oligopeptide with melanin inhibitory activity, tandem protein, composition and application thereof, and relates to the technical field of whitening. The oligopeptide comprises oligopeptides consisting of at least one of the following amino acid sequences: NL, NLP, NLPS, NLPSSP, NLF, YNLF, VLYNLF, YNLFTR, VLDYNLFTR, VLYNLFTR, YNLL and YNLLEDFK. The oligopeptide provided by the invention can promote the generation rate of melanin to be obviously reduced and inhibit the generation of melanin, and has the effect of preventing or improving skin pigmentation. Besides, the oligopeptide also has an effect of promoting melanin body membrane degradation and has an effect of promoting melanin degradation, so that the oligopeptide has a good application prospect in cosmetics, foods, medicines and other products for relieving or improving hyperpigmentation.
Owner:OSMUN BIOLOGICAL CO LTD

Functional cyclic peptide as well as preparation method and application thereof

The invention discloses a functional cyclic peptide as well as a preparation method and application thereof, belongs to the technical field of synthesis and application of cyclic peptides, and particularly relates to a functional cyclic peptide with a cyclic structure, which is prepared by activating an amino acid reagent to obtain a linear peptide containing a protecting group and then cyclizing the linear peptide. The functional cyclic peptide prepared by the invention has the advantages of good moisturizing effect, good anti-wrinkle effect, good tightening effect, good soothing effect, good neurotransmitter release inhibition effect and good whitening effect. After the linear peptide is prepared into the functional cyclic peptide, the permeability, the stability and the activity are improved, and the irritation is reduced.
Owner:ZHEJIANG PEPTITES BIOTECH CO LTD +1

Methods and compositions for delivery of biotin to mitochondria

Certain exemplary embodiments are directed to a biologically active composition of matter (and uses thereof) configured for targeted delivery of biotin to mitochondria, the composition comprising a first D-biotin conjugated to a water-soluble, cell-permeable, peptide sequence, wherein the peptide sequence is selected from a polypeptide group with an alternating aromatic-cationic motif.
Owner:SOCIAL PROFIT NETWORK

Cyclic pentapeptide-4 as well as preparation method and application thereof

The invention discloses cyclic pentapeptide-4 as well as a preparation method and application thereof, belongs to the technical field of synthesis and application of cyclic peptides, and particularly relates to a functional cyclic peptide with a cyclic structure, which is prepared by activating an amino acid reagent to obtain a linear peptide containing a protecting group and then cyclizing the linear peptide. The functional cyclic peptide prepared by the invention has the advantages of good moisturizing effect, good anti-wrinkle effect, good tightening effect, good soothing effect, good neurotransmitter release inhibition effect and good whitening effect. After the linear peptide is prepared into the functional cyclic peptide, the permeability, the stability and the activity are improved, and the irritation is reduced.
Owner:ZHEJIANG PEPTITES BIOTECH CO LTD +1

Antibody-drug conjugate, method for preparing same, and use thereof

Provided are an antibody-drug conjugate, a method for preparing same, and use thereof. The antibody-drug conjugate has a structure represented by formula Ab-[M-L-E-D] x, a superior drug-to-antibody ratio, and an excellent targeted killing effect on various cancers or tumors.
Owner:SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD

New antithrombotic antibodies

The present invention provides a novel antithrombotic antibody, which targets FIXa and has unique properties, specifically targets the binding site of blood coagulation factors FIXa and FVIIIa, reduces the formation of FVIIIa-FIXa complex, blocks the conversion of FX to FXa, and exerts antithrombotic effects. The antibody of the present invention has suitable antithrombotic properties, has a wide effective therapeutic concentration window, but does not increase the risk of bleeding; it can realize the demand for moderate antithrombotic properties in clinical applications and effectively avoid bleeding problems caused by excessive effects. The present invention also discloses a method for screening drugs that target the FIXa-FVIIIa binding site.
Owner:SHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD

Camptothecin derivative

Disclosed herein are novel cytotoxic compounds, and cytotoxic conjugates comprising these cytotoxic compounds and cell binding agents. More specifically, the present disclosure relates to novel camptothecin derivatives thereof, intermediates thereof, conjugates thereof, and pharmaceutically acceptable salts thereof, which are useful as medicaments, particularly as antiproliferative agents (anticancer agents).
Owner:IMMUNOGEN INC

Radiolabeled compounds targeting prostate-specific membrane antigen - Patents.com

A compound comprising a prostate-specific membrane antigen (PSMA) targeting moiety of the following formula: R 0 is O or S. 1a , R 1b and R 1c Each of R may be, for example, —COH, —SOH, —SOH, —POH, or —POH. 2 R may be an optionally substituted methylene or a derivative thereof, propylene or a derivative thereof, or a derivative of ethylene. 3 is a linker. When the PSMA targeting moiety is attached to a radiolabeling group, the compound may be used as an imaging agent or a therapeutic agent for diseases / conditions that express PSMA. TIFF2022537773000240.tif2237
Owner:PROVINCIAL HEALTH SERVICES AUTHORITY +1

Anti-hair-loss hair-care component, preparation method thereof and shampoo

The invention discloses an anti-hair loss hair care component, a preparation method of the anti-hair loss hair care component and shampoo. The anti-hair loss hair care component is ionic salt formed by R-Lys-Gly-His-Lys-NH2 and oleanolic acid, wherein R is palmitoyl or myristoyl; the composition has high-temperature storage stability, transdermal property and HDPCs proliferation promotion effect in an aqueous solution environment, so that hair loss prevention and hair growth are promoted. The ionic salt is prepared in an atomization mixing mode, and the method has the advantages of being high in product purity, high in reaction efficiency and simple in process. The invention also provides a shampoo containing the anti-hair loss and hair care component, and the shampoo has proper viscosity and pH value.
Owner:GUANGZHOU SUN SARA COSMETIC CO LTD

Cyclic peptide, and composition and use thereof

The present disclosure relates to the technical field of polypeptides. Disclosed are a cyclic peptide, and a composition and the use thereof. The cyclic peptide of the present disclosure has a structure as shown in formula (I): Cyclo-[Gly-His-Lys-Lys] (I). The present disclosure specifically relates to the cyclic peptide or a salt thereof, or a composition thereof, and the use thereof in the preparation of a composition for caring or treating skin or mucosa.
Owner:SHENZHEN WINKEY TECHNOLOGY CO LTD

Coacervate-forming reagents and methods

The invention relates to coacervate-forming polymers having defined structural formulae. The invention also relates solutions comprising the coacervate-forming polymers and methods of making solutions comprising the coacervate-forming polymers. The invention also relates to polymer coacervates, comprising the coacervate-forming polymers within the coacervates, including polymer coacervates comprising cargo compounds, and methods for making such polymer coacervates. The coacervates of the invention are capable of penetrating into cells and thereby delivering cargo compounds into cells. The invention further relates to compositions, including pharmaceutical compositions, comprising the polymer coacervates. The invention also relates to uses of the coacervate-forming polymers, including medical uses.
Owner:PARTITIONBIO LTD

Cyclic octapeptide-3 as well as preparation method and application thereof

The invention discloses a cyclic octapeptide-3 as well as a preparation method and application thereof, belongs to the technical field of synthesis and application of cyclic peptides, and particularly relates to a functional cyclic peptide with a cyclic structure, which is prepared by activating an amino acid reagent to obtain a linear peptide containing a protecting group and then cyclizing the linear peptide. The functional cyclic peptide prepared by the invention has the advantages of good moisturizing effect, good anti-wrinkle effect, good tightening effect, good soothing effect, good neurotransmitter release inhibition effect and good whitening effect. After the linear peptide is prepared into the functional cyclic peptide, the permeability, the stability and the activity are improved, and the irritation is reduced.
Owner:ZHEJIANG PEPTITES BIOTECH CO LTD +1

Glucose-sensitive insulin derivatives

The present invention relates to novel insulin derivatives and their use in the treatment or prevention of medical conditions associated with diabetes. The insulin derivatives are glucose-sensitive and exhibit glucose-sensitive albumin binding. The present invention also relates to novel intermediates. Finally, the present invention provides pharmaceutical compositions comprising the insulin derivatives of the present invention and the use of such compositions in the treatment or prevention of medical conditions associated with diabetes.
Owner:NOVO NORDISK AS

Methods and compositions for detecting and diagnosing renal and periodontal disease - Patents.com

Compositions and methods for detecting renal and periodontal disease in mammals are provided. The present disclosure provides a method for detecting and measuring the level of cystatin B polypeptide in a sample using an antibody, and if the level is higher than that of a control, it is an indication of kidney disease or periodontal disease.
Owner:IDEXX LABORATORIES INC

Conjugates for treating diseases caused by PSMA expressing cells

The invention described herein pertains to the diagnosis, imaging, and / or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and / or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
Owner:ENDOCYTE INC

Polypeptide compound and application thereof in treating enteritis

The invention relates to a novel polypeptide and application thereof. The polypeptide provided by the invention is short in peptide chain and faster and better in absorption. Experimental results show that the polypeptide provided by the invention shows an obvious enteric cavity dilatation relieving effect in pharmacodynamic tests of a zebra fish inflammatory bowel disease model and a rat inflammatory bowel disease model. The polypeptide provided by the invention has a remarkable colitis relieving effect, and can be used for preparing a medicine for treating enteritis, especially a medicine for treating ulcerative colitis.
Owner:SICHUAN GOODDOCTOR PANXI PHARMA

Novel pace4 inhibitor and use thereof in Anti-osteoarthritis

PCT designated stage expiredWO2025097674A1AntipyreticAnalgesicsBlood plasmaPharmacology
A novel PACE4 inhibitor and use thereof in anti-osteoarthritis. A novel PACE4 inhibitory peptide is designed and synthesized, which can effectively inhibit the expression of extracellular PACE4 without affecting normal cells, and is stable in joints and unstable in plasma, so that the PACE4 inhibitory peptide has excellent safety and can be effectively used in the prevention and treatment of OA.
Owner:INFLAMAX PHARM LTD

Antibody conjugates for targeting Trop-2-expressing tumors

The present invention relates to an antibody conjugate that is particularly suitable for targeting Trop-2 expressing cells, especially tumor cells. The antibody conjugate according to the invention has the structure (1), where AB is an antibody capable of targeting Trop-2 expressing tumors, L is a linker connecting Z to D, Z is a connecting group, and L 6 -GlcNAc(Fuc) w -(G) j -S-(L 7 ) w’ -, in which G is a monosaccharide, j is an integer ranging from 0 to 10, S is a sugar or a sugar derivative, GlcNAc is N-acetylglucosamine, Fuc is fucose, w is 0 or 1, w' is 0, 1, or 2, and L 7 is -N(H)C(O)CH2-, -N(H)C(O)CF2-, or -CH2-, D is exatecan, b is 0 or 1, x is 1 or 2, and y is 1, 2, 3, or 4. The present invention further relates to methods for preparing the antibody conjugates of structure (1) and applications of the antibody conjugates of structure (1).
Owner:SYNAFFIX BV

Anti-aging compositions and methods of use thereof

Compositions comprising specific tetrapeptides, for use in treating, preventing, minimizing, diminishing or reversing various signs of aging of the skin are provided. The compositions are useful in improving the firmness or elasticity of skin, smoothing of fine-lines or wrinkles, reducing skin pores and hyperpigmentation, and increasing skin thickness, radiance and / or softness.
Owner:S I S SHULOV INST FOR SCI LTD

Polypeptide compound and its use in treating enteritis

The present invention relates to a new polypeptide and its application. The polypeptide provided by the present invention has a short peptide chain and is absorbed faster and better. Experimental results show that the polypeptide provided in this application exhibits an obvious effect of alleviating intestinal lumen dilation in the zebrafish inflammatory bowel disease model and the rat inflammatory bowel disease model. The polypeptide provided by the present invention has a significant effect of alleviating colitis and can be used to prepare drugs for treating enteritis, especially drugs for ulcerative colitis.
Owner:SICHUAN GOODDOCTOR PANXI PHARMA

Soluble biomolecular glass and its use

The present invention provides biomolecular glass and its use. The biomolecular glass is obtained by volatilizing a solvent from a solution of biomolecular raw materials, the solution of biomolecular raw materials comprising biomolecular raw materials, a modifier, and a solvent. The biomolecular raw materials include natural amino acids, peptides, amino acid derivatives, peptide derivatives, or mixtures of two or more of the above. The soluble biomolecular glass of the present invention has excellent biocompatibility, high light transmittance, good mechanical strength, flexible processability, and biodegradability, and can be processed into implantable or non-implantable medical materials and / or devices, fillers and stent materials, electronic sensing materials and / or devices, temporary electronic materials and / or devices, etc., and can be decomposed by living organisms or nature, with decomposition products being non-contaminating.
Owner:INSTITUTE OF PROCESS ENGINEERING CHINESE ACADEMY OF SCIENCES

Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

The present invention relates to a method of preparing a salt of a β-turn peptidomimetic cyclic compound of formula (I) where R1, R2, R3, R4, R5, R6, R7, R8, R10, X, Y and n are as defined in the description, in particular a method of preparing a β-turn peptidomimetic cyclic compound having the following structure:
Owner:MIMETOGEN PHARMA

Method for efficient peptide condensation of high difficulty sequences

To provide a method for producing a high-purity peptide compound in a high yield under a condensation condition applicable even to a highly rare non-natural amino acid by using an easily available condensing agent and additive capable of suppressing prematurecleavage and also suppressing a side reaction especially in a condensation reaction process of a solid phase synthesis method of a peptide.SOLUTION: Provided is a method for producing a peptide compound, including a step of condensing a first amino acid or peptide and a second amino acid or peptide in the presence of an additive and a condensing agent to obtain a condensate, wherein the number of moles of the additive is smaller than the number of moles of the second amino acid or peptide. By using a small amount of the additive with respect to the amino acid or peptide to be added to the N-terminus, the condensation reaction can be allowed to proceed efficiently even when an amino acid having large steric hindrance is contained, and the target peptide compound can be obtained with high yield and high purity.SELECTED DRAWING: None
Owner:CHUGAI PHARMA CO LTD

Ligand drug conjugates with improved pharmacokinetic and drug release properties - Patents.com

PendingJP2025512064AAntibacterial agentsAntivirals
The present invention relates to ligand drug conjugates for the treatment of diseases. In particular, the present invention relates to ligand drug conjugates comprising a linker system that allows improved delivery of drugs to target cells while retaining the favorable pharmacokinetic properties of antibodies. The present invention also relates to ligand drug conjugates that achieve high drug-antibody ratios and exhibit excellent pharmacokinetic properties, thus significantly improving efficacy. In one aspect, the present invention also relates to ligand drug conjugates for intracellular delivery of cytotoxic drugs to tumor or cancer cells.
Owner:デバイオファーム リサーチ アンド マニュファクチュアリング エスエー